Abstract
Eddy and colleagues are to be commended on this comprehensive, global synthesis of qualitative evidence (22 studies), reporting on barriers and facilitators of magnesium sulphate use for eclampsia prevention and treatment. Almost all of the 22 studies were from low-and-middle-income countries that bear most of the burden of pre-eclampsia-related morbidity and mortality. The analysis accounted for the perspectives of healthcare providers, facilitator administrators, and policy-makers, all organised according to the COM-B model of behaviour change theory, according to stakeholders' capability, opportunity, and motivation to use magnesium sulphate appropriately.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
